EUROPEAN RESEARCH AND PREPAREDNESS NETWORK FOR PANDEMICS AND EMERGING INFECTIOUS DISEASES

EU-RESPONSE is funded by the European Union’s Horizon 2020 research and innovation programme.

Firstly, the project focuses on the expansion of the DisCoVery trial in Europe, to test potential treatments for COVID-19. Secondly, based on the experience acquired from DisCoVery, EU-RESPONSE aims to design and run a new adaptive European platform trial for emerging infectious diseases, called EU-SolidAct, thus improving Europe’s responsiveness to pandemic crises.

icon-partners

21
Partners

icon-countries

17
Countries

icon-patients

I am a patient

You are a patient and you have questions about DisCoVery and clinical research on COVID-19.

icon-team

The Team

Meet the scientists behind EU-RESPONSE.